Postoperative Delirium in Surgical Patients — HELP Prevention, Depth Controversy, Drug Verdicts and Prognosis

The confused postoperative patient is delirious until proven otherwise — so define it by DSM-5 attention-and-awareness criteria, stratify with Marcantonio or Rudolph before the operation, screen with 4AT or CAM after it, prevent with the six-target HELP bundle that halved incidence in the original trial and across its meta-analysis, and treat causes rather than symptoms: because multicomponent care cuts delirium by a third while antipsychotics neither prevent (Oh, high-strength evidence) nor shorten (MIND-USA) it, dexmedetomidine's benefit depends on timing and population, EEG-guided depth failed its flagship trial, and delirium predicts death, dependence and dementia for years.^{[5][1][2][35][57][44][61]}

Day 1 after hip hemiarthroplasty, an 82-year-old woman with dementia is quietly inattentive, disoriented, off food, with a catheter in situ and morphine on the chart. Is this hypoactive delirium or dementia, which preoperative score predicted it, which six bundle elements start today, which two drugs do you stop, does switching her anaesthetic have helped, and what do you tell the family about the year ahead? The examiner will watch you screen rather than guess, quote the trials behind each move, refuse antipsychotic prophylaxis with numbers, and book follow-up. This page teaches each move with every number taken from the paper named beside it.^{[18][7][1][42][52][61]}

Definition & Phenomenology — acute, fluctuating, inattentive

Postoperative delirium is defined per DSM-5 criteria as an acute disturbance of attention and awareness with fluctuation — the definition the European anaesthesia/intensive-care guideline adopts, requiring a validated screening tool at least daily for three days from the recovery room.^[5] The bedside picture is broader than the definition: across 62 postoperative studies and 11,377 patients, 78 differently described symptoms were reported, most often inattention, disorientation, psychomotor agitation or retardation, hallucination and memory impairment — yet psychomotor agitation and hallucinations are not listed in the DSM-5-TR delirium definition itself.^[6] That gap is the examined trap: binary present/absent reporting dumps subsyndromal patients into the control group and hides the very symptoms — inattention first — that carry the diagnosis.^[6]

Delirium is distinguished from dementia by acuity and fluctuation against a chronic progressive baseline, and from delayed neurocognitive recovery by timing: delirium declares itself in days, delayed recovery persists to 30 days, postoperative neurocognitive disorder to 12 months.^[55][24] The distinction governs consent, discharge destination and follow-up — and a delirious brain can unmask a dementia that then declares itself within the year.^[61]

Epidemiology — how often, in whose operation

Hip fracture is the index operation: pooled postoperative delirium prevalence is 23% across 13 cohorts and 18,850 elderly patients.^[16] The recovery room is the next net: 19.2% of 2200 older elective major-noncardiac patients were CAM-positive in PACU, nearly two-thirds of it hypoactive — the quiet kind gestalt misses.^[18] At national scale, 10.6% of 217,783 screened NSQIP patients aged 75 and over were delirious — yet only 7.3% of all surgical patients were screened at all, with screening rates falling as age rose while positivity climbed from 3.1% at 75–79 to 12.8% past 90.^[17] Cardiac surgery concentrates further: 52% in Rudolph's derivation cohort, 50–90% quoted across the cardiac-ICU literature, 28.4% even on placebo after thoracic surgery.^[8][59][36] Every rate needs its denominator stated — case-mix, instrument (CAM versus coding versus EHR) and timing (PACU versus day 5) move the number more than biology does.^[10]

Pathophysiology — seven theories, one transmitter derangement

Maldonado's synthesis runs seven complementary theories — neuroinflammatory, neuronal ageing, oxidative stress, neurotransmitter deficiency, neuroendocrine, diurnal dysregulation and network disconnectivity — converging on altered synthesis, function and availability of transmitters.^[20] The signature to recite: deficient acetylcholine and melatonin, excess dopamine, norepinephrine and glutamate, variable serotonin, histamine and GABA with presentation.^[20] The modern frame is predisposition multiplied by trigger — vulnerability (age, cognitive impairment, frailty, comorbidity) meeting insult (surgery, inflammation, drugs, sleep loss, catheters) across a breached blood–brain barrier.^[21] In 2026 live human brain multi-omics made the inflammation concrete: POD-specific microglial transcriptional programmes with enhanced neuroinflammatory signatures, astrocytic synaptic remodelling and immune epigenetic shifts — glial priming as mechanism, not metaphor.^[22] The microglial-priming model explains exactly who breaks: the brain whose immune landscape — cell states, activation thresholds, resolution capacity — was already primed by age, frailty or neurodegeneration.^[24][23] And the honest stop-line: inflammatory, neurodegenerative, metabolic and stress markers notwithstanding, no biomarker is established for routine clinical use.^[21]

Risk Prediction — scores stratify, bundles prevent

Marcantonio's 1994 rule remains the preoperative standard for noncardiac surgery: seven factors available before the knife — age 70 or older, self-reported alcohol abuse, poor cognitive status, poor functional status, markedly abnormal sodium/potassium/glucose, noncardiac thoracic surgery, aortic aneurysm surgery — stratifying 1341 patients (9% delirious) into 2%, 8–13% and 50% risk groups.^[7] For cardiac surgery, Rudolph's four variables — prior stroke or TIA, MMSE band, abnormal albumin, depression score — predicted 19%, 47%, 63% and 86% across point levels in derivation (C 0.74) and 18%, 43%, 60% and 87% in validation (C 0.75).^[8] PROPDESC modernises this onto routine preoperative data with validation AUC 0.729 — pragmatic, not magic.^[9] Electronic-record models reach internal AUCs of 0.77–0.97 across 29 studies but only 12 reported external discrimination and 15 calibration: no single algorithm is ready for routine adoption.^[10] The bedside list needs no model: prior delirium (odds 6.44), ASA above 4 (4.19), dementia (3.42), frailty (2.39), malnutrition (2.16), low MMSE (2.21), high 4AT (3.04), delayed surgery (1.74), blood loss and comorbidity burden.^[16][19] And scores only stratify: moving geriatric consultation earlier changed nothing (adjusted odds 1.09) — it is the consult's content, not its timing, that prevents.^[32]

Screening & Diagnosis — 4AT, CAM and the ward round

On the ward, the 4AT is the instrument of choice: in 274 critically ill patients it detected delirium with AUC 0.879 — sensitivity 74.0%, specificity 95.4%, accuracy 91.7% — against CAM-ICU's 71.3%, 97.1% and 92.6%.^[11] The network meta-analysis of 50 studies and 6042 ICU patients confirms the pairing: CAM-ICU specificity 0.949, 4AT balanced but unsuitable for ventilated patients — and the Delirium Detection Score, sensitivity 0.302, must never be used to rule anything out.^[12] For the non-intubated post-cardiac patient, CAM-IMC fuses CAM-ICU items with verbal disorientation testing to reach sensitivity 0.96, specificity 0.94 and AUROC 0.95.^[13] In the emergency department, 4AT rules in (LR+ 7.5) and rules out (LR− 0.18) delirium around test/treat thresholds of 2% and 11% — while clinician gestalt, though it can rule delirium in, is inadequate to rule it out.^[14] Australasian reality-check: detected prevalence 16%, assessment rates 63%, 4AT and CAM the commonest tools, written protocols on 91% of wards — yet antipsychotics still frequent on a third of charts, with staffing and training the named barriers.^[15]

Prevention I — HELP: the six-target bundle that works

Inouye's 1999 trial randomised 852 medical inpatients aged 70 and over to standardised protocols for six risk factors — cognitive impairment, sleep deprivation, immobility, visual impairment, hearing impairment, dehydration — and cut delirium from 15.0% to 9.9% (matched odds 0.60), delirium-days from 161 to 105, episodes from 90 to 62, at 87% adherence.^[1] Severity and recurrence did not move — hence the dictum that primary prevention is probably the most effective treatment strategy.^[1] The 2018 meta-analysis scaled it: 14 pooled studies, delirium odds 0.47, falls down 42%, $1600–3800 saved per admission plus $16,000 per long-term-care person-year — the reference-standard model of hospital elder care.^[2] Cochrane's 39 trials and 16,082 non-ICU patients agree: multicomponent care cuts delirium (RR 0.69 overall, 0.71 surgical, moderate-quality) — while in pre-existing dementia the effect is uncertain (RR 0.90, single small study) and cholinesterase inhibitors show no clear effect.^[3] Translation to hips works through nurses: delirium-friendly preprinted orders executed by regular orthopaedic staff cut delirium from 51% to 33% (p=.001), strongest with dementia (97% to 60%).^[29] Add the family: flexible daytime visitation in orthopaedic ICU cut delirium from 44.4% to 29.5% in 405 randomised patients.^[30] The AGS guideline and ESAIC update both enshrine the doctrine — primary prevention in at-risk patients, multicomponent measures across all three perioperative phases.^[4][5]

Prevention II — drugs: rankings with brakes

The network meta-analyses rank prophylaxis as atypical antipsychotics (odds 0.27), haloperidol (0.42), dexmedetomidine (0.51) and melatonergics (0.57) across 44 randomised trials and 11,178 elderly patients — explicitly indirect evidence demanding confirmatory trials.^[33] Park's 86-trial network concurs on the order but applies the brake: heterogeneity of diagnostic windows and small-study effects preclude firm conclusion.^[34] The AHRQ review then closes the antipsychotic door: haloperidol equals placebo for incidence, duration, stay and mortality at high strength of evidence — current evidence does not support routine haloperidol or second-generation prophylaxis, with only a limited postoperative second-generation signal surviving.^[35] Thoracic surgery proved it at the bedside: low-dose haloperidol 22.1% versus placebo 28.4% (p=.43), no difference in time, duration, severity or stay — the esophagectomy subgroup hint (p=.16) is hypothesis, not licence.^[36] Dexmedetomidine splits by timing and population: perioperative infusion in cardiac surgery cuts delirium (RR 0.67, trial-sequential conclusive; RR 0.70 in the 2026 update) — but at low-to-moderate quality, with weak saline-placebo signal and a bradycardia cost demanding monitored individualisation.^[38][39] Intraoperative-only infusion in major noncardiac surgery failed outright (12.2% versus 11.4%) — ICU-sedation benefit does not transfer across the drapes, and timing owns the verdict.^[37] Under spinal with fascia-iliaca block for hips, dexmedetomidine sedation beat propofol sedation (4.0% versus 7.8%) — comparator, not drug alone, decides.^[40] Esketamine's RR of 0.57 across 22 trials is real but China-only at low GRADE certainty: promising, not doctrine.^[41] Whether ephedrine beats phenylephrine for pressure-supported delirium prevention remains uncertain — a 1084-patient trial is asking, not answering.^[56]

Anaesthetic Depth — the examined controversy

Prosecute the positive: Evered randomised 655 at-risk major-surgery patients to BIS 50 versus BIS 35 and found delirium 19% versus 28% (odds 0.58) with better 1-year cognition (9% versus 20% impaired).^[46] Two 2025–26 meta-analyses agree processed-EEG guidance cuts delirium (RR 0.81, elderly and noncardiac benefit; RR 0.77) without touching later cognition.^[47][48] Defend the null: ENGAGES randomised 1232 older adults to EEG-guided versus usual care and found delirium 26.0% versus 23.0% (p=.22) — despite 7 versus 13 suppression-minutes and 0.69 versus 0.80 MAC volatile.^[44] BALANCED randomised 6644 high-risk patients to BIS 50 versus 35 and found 1-year mortality 6.5% versus 7.2% — light anaesthesia not superior for survival.^[45] Wang's meta-analysis dissents from Evered (OR 1.40, non-significant, low-quality; long-term nulls high-quality).^[49] The honest synthesis names the differences: BIS-target-versus-BIS-target is not guided-versus-usual; cardiac mix, comorbidity and regional practice (Europe/Asia benefit, North America null) shift the answer; frontal-only indices miss whole-brain vulnerability that burst suppression and emergence trajectories capture.^[47][50] The pilot factorial (n=78: dex −10%, light −11%, confidence intervals crossing zero) proves a full trial feasible — quoting it as effect is fabrication.^[51]

Anaesthetic Technique — spinal, volatile and sedation verdicts

Observational data flatter regional anaesthesia — general anaesthesia odds 1.53 in the hip meta-analysis and 1.88 in the hemiarthroplasty cohort.^[16][19] Randomised data refuse: ten trials and 3968 hip-fracture patients found neuraxial versus general delirium odds 1.10 (0.89–1.37), and a 161-patient GA-versus-spinal RCT found overall similar cognition, function and short-term prognosis.^[52][53] Choose technique for patient and operation; prevent delirium with the bundle.^[52][2] Volatile versus intravenous maintenance is likewise settled toward indifference: 29 trials and 11,896 patients found delirium identical (RR 0.94), delayed recovery possibly raised but heterogeneous (RR 1.35), MMSE 1.4 points lower and meaningless — intravenous anaesthesia does not meaningfully improve neurocognitive outcomes.^[54] Desflurane versus propofol in 126 urological patients found POD 14.1% versus 9.8% (non-significant) with longer delirium days on desflurane — exploratory, small numbers, quoted with both tags — alongside an IL-6 POD signal worth watching.^[55]

Drugs That Harm — opioids and anticholinergics

Among 7700 patients (22.1% delirious), any opioid raised delirium odds (1.15) — morphine to 1.42, postoperative administration to 1.92, and meperidine to 3.36: the drug the elderly must never receive.^[42] Untreated pain also precipitates delirium, so the answer is multimodal analgesia with regional blocks — fascia-iliaca catheters, not bigger morphine doses.^[40][42] Anticholinergic burden earns its medication review: overall duration/severity showed no link, but haloperidol's halving trend survived only at nil-to-low burden — high-burden brains gain the harm without the hint of help.^[43] The ward audit's shame — antipsychotics on a third of delirium charts — is fixed by protocol and pharmacist review, not by new evidence.^[15][57]

Hip Fracture & Orthogeriatric Co-care — the index pathway

The 84-year-old hip fracture with dementia concentrates every lesson: 23% delirium risk, frailty and malnutrition multipliers, delayed surgery as an independent predictor (odds 1.74), and dementia nearly tripling long-term delirium incidence in the Taiwanese nationwide cohort.^[16][19] Orthogeriatric collaboration halves in-hospital mortality (RR 0.60) and trims long-term death (0.83) and stay — though delirium and function were measured too infrequently to claim more.^[31] Run the pathway: operate early, screen with 4AT (admission score odds 3.04), review drugs, hydrate, oxygenate, block pain, protect sleep, remove catheters, invite family — the planks Inouye, Freter and Ke each proved.^[1][29][30] And remember Aydin: 1776 patients, pre- versus post-operative first consult, delirium 19.7% versus 19.5% — presence of geriatrics is not the same as geriatrics changing care.^[32]

Cardiac Surgery Delirium — high incidence, new signals

Half of cardiac patients become delirious, and the Rudolph rule tells you which half before bypass: stroke history, MMSE band, albumin, mood — 19% to 86% across point strata.^[8] New signals refine but do not replace: 72-hour fever burden independently predicts (adjusted odds 2.13), lactate-to-albumin ratio predicts (1.51), monocyte above 5.4% trends pending validation, preoperative C1q reaches AUC 0.788 in a single 67-patient aortic cohort.^{[27][25][26][28]} Dexmedetomidine's best case is here — with the bradycardia and quality caveats attached.^[38][39] Established cardiac-ICU delirium has no drug answer: the treatment review found 50–90% incidence with heterogeneity blocking any meta-analysis, and MIND-USA's null covers hypoactive and hyperactive alike.^[59][57] Work the cause list — infection, low output, hypoxia, electrolytes, retention, drugs, pain — before any sedative, and the examiner passes you.^[5]

Treatment — what shortens nothing, what still works

MIND-USA is the treatment anchor: 566 delirious ICU patients with respiratory failure or shock, 89% hypoactive, randomised to haloperidol, ziprasidone or placebo — 8.5, 7.9 and 8.7 days alive without delirium or coma (p=.26), no secondary or safety differences.^[57] With REDUCE, that is two negative antipsychotic trials: strong evidence they neither prevent nor shorten delirium.^[58] What works is unglamorous: find and reverse each cause, restore sleep, mobility, hydration, vision and hearing, rationalise every drug, bring the family in, avoid restraints and benzodiazepines outside withdrawal — the AGS treatment goals (less severe, shorter, safer) and ESAIC's team-based measures.^[4][5] Antipsychotics survive only as exception: severe agitation endangering safety despite everything, lowest dose, shortest course, QT and extrapyramidal watch — framed as exception, never strategy.^[35][57] The ABCDEF bundle is ICU-adopted with potential benefit in reviews — potential, not proven cure.^[58]

Prognosis — death, dependence, dementia

Delirium is a prognosis, not an episode. NSQIP: 30-day mortality odds 3.2, reoperation 2.3, complications 1.8, lost independence 1.6, home discharge halved.^[17] Surgical ICU at one year: death 44.1% versus 18.3% (adjusted hazard 1.49), dependency risk up by a quarter.^[60] Major surgery at one year: new dementia odds 13.9 — the strongest factor found — with mortality tripled and readmission nearly doubled.^[61] Cardiac surgery at three years: 42.8% with death, lost quality of life or lost independence — delirium altering the whole trajectory.^[62] Prevention is therefore survival medicine, and every delirium survivor needs cognitive follow-up booked before discharge.^[61][4]

Evidence, Guidelines & Regional Differences — who proved what, where

America's geriatrics panel wrote the best-practice statement and abstracted guideline for older surgical patients; Europe's anaesthesia/intensive-care societies updated the perioperative evidence guideline through 2022 literature; the HELP investigators built the reference-standard bundle from a 1999 NEJM trial to a cost-saving meta-analysis.^[4][5][1][2] The trial geography is American for depth (ENGAGES, MIND-USA, BALANCED's international lead with Australian coordination), German-Australian for depth-mortality (BALANCED), Chinese for PACU and sedation signals, Taiwanese for nationwide hip data, Thai-Australian for the SICU cohort — a genuinely global evidence base for a global examination.^{[44][45][57][18][60]} Australasia contributes the implementation audit: protocols everywhere, practice improving, workforce the constraint.^[15]

Exam Pearls — the one-liners that score

• Fluctuating inattention is the definition; agitation and hallucination are common but outside DSM-5-TR — name both facts together.^[5][6]
• Hip fracture 23%, PACU 19% (two-thirds hypoactive), NSQIP 10.6% of the screened few — always state the denominator.^[16][18][17]
• Marcantonio 2/8–13/50% and Rudolph 19→86% stratify; PROPDESC 0.729 and EHR models (none ready) do not replace them.^{[7][8][9][10]}
• 4AT matches CAM-ICU off the ventilator; CAM-IMC adds disorientation (0.96/0.94); DDS 0.30 sensitivity must never rule out.^[11][13][12]
• HELP halves delirium (OR 0.47–0.60) and pays for itself; Cochrane surgical RR 0.71; nurses' order sets 51→33%.^{[1][2][3][29]}
• Haloperidol prophylaxis fails (high-SOE null; thoracic 22 vs 28%); MIND-USA fails treatment (p=.26) — prophylaxis and treatment nulls are separate answers.^[35][36][57]
• Dexmedetomidine works perioperatively in cardiac (RR 0.67–0.70, bradycardia cost) and as hip-spinal sedation (4.0 vs 7.8) — but not as intraop infusion in noncardiac (12.2 vs 11.4).^[38][40][37]
• ENGAGES neutral, BALANCED neutral-mortality, Evered positive, metas split by continent — the controversy IS the answer.^{[44][45][46][47]}
• Spinal does not beat general for delirium (OR 1.10); volatile does not lose to IV (RR 0.94) — technique follows indication, bundle follows patient.^[52][54]
• Meperidine triples delirium (OR 3.36); high anticholinergic burden erases haloperidol's hint — review drugs before adding them.^[42][43]
• Delirium predicts death (OR 3.2, aHR 1.49), dependence and dementia (OR 13.9) — follow every survivor.^[17][60][61]

Revision summary

Postoperative delirium is an acute fluctuating attention disorder (DSM-5), commonest after hip fracture (23%) and cardiac surgery (half), mostly hypoactive and under-screened. Stratify with Marcantonio (2/8–13/50%) or Rudolph (19→86%); screen with 4AT/CAM (CAM-IMC 0.96/0.94 off the ventilator). Prevent with HELP's six targets (OR 0.47–0.60, falls and costs down) plus visitation and order sets; anaesthetise by indication since EEG guidance (ENGAGES neutral), depth (BALANCED neutral) and spinal-versus-general (OR 1.10) do not settle delirium. Avoid meperidine (OR 3.36) and routine antipsychotics (high-SOE prevention null, MIND-USA treatment null); use dexmedetomidine selectively in cardiac/hip-spinal settings with monitoring. Delirium predicts 30-day death (OR 3.2), 1-year dementia (OR 13.9) and 3-year decline — arrange cognitive follow-up.^{[5][16][7][11][1][44][52][42][57][61]}

References62ShowHide

1. [1]Inouye SK, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med, 1999.PMID 10053175
2. [2]Hshieh TT, et al. Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness. Am J Geriatr Psychiatry, 2018.PMID 30076080
3. [3]Siddiqi N, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev, 2016.PMID 26967259
4. [4]American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults, et al. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc, 2015.PMID 25495432
5. [5]Aldecoa C, et al. Update of the European Society of Anaesthesiology and Intensive Care Medicine evidence-based and consensus-based guideline on postoperative delirium in adult patients. Eur J Anaesthesiol, 2024.PMID 37599617
6. [6]Bowman EML, et al. Assessment and report of individual symptoms in studies of delirium in postoperative populations: a systematic review. Age Ageing, 2024.PMID 38640126
7. [7]Marcantonio ER, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA, 1994.PMID 8264068
8. [8]Rudolph JL, et al. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation, 2009.PMID 19118253
9. [9]Menzenbach J, et al. PRe-Operative Prediction of postoperative DElirium by appropriate SCreening (PROPDESC) development and validation of a pragmatic POD risk screening score based on routine preoperative data. J Clin Anesth, 2022.PMID 35190344
10. [10]Huang HM, et al. Prediction Models for In-Hospital Delirium Using Routinely Collected Electronic Health Record Data: Systematic Review. JMIR Med Inform, 2026.PMID 42748492
11. [11]Sim JK, et al. Usefulness of the 4A's test for detecting delirium in critically ill patients: a multicenter prospective observation study. Intern Emerg Med, 2024.PMID 38907758
12. [12]Li N, et al. Diagnostic Accuracy of Screening Tools for Delirium in Adults Receiving Care in Intensive Care Units: A Systematic Review and Network Meta-Analysis. Nurs Health Sci, 2026.PMID 42077053
13. [13]Beyer LP, et al. Disorientation as a delirium feature in non-intubated patients: development and evaluation of diagnostic accuracy of the 'Confusion Assessment Method for Intermediate Care Unit' (CAM-IMC) - a prospective cohort study. BMC Anesthesiol, 2024.PMID 39673057
14. [14]Carpenter CR, et al. Delirium detection in the emergency department: A diagnostic accuracy meta-analysis of history, physical examination, laboratory tests, and screening instruments. Acad Emerg Med, 2024.PMID 38757369
15. [15]Huang S, et al. Detected Delirium Prevalence and Practices in Australia and New Zealand: A Sub-Analysis of the World Delirium Awareness Day Prevalence Study. Australas J Ageing, 2026.PMID 42656048
16. [16]Hu Y, et al. Prevalence and risk factors for postoperative delirium after hip fracture in the elderly: A systematic review and meta-analysis. Medicine (Baltimore), 2026.PMID 41578567
17. [17]Panayi AC, et al. Delirium after surgery: a retrospective study of predictors, complications, and screening patterns in the national surgical quality improvement program. EClinicalMedicine, 2025.PMID 41497512
18. [18]Ma X, et al. PACU Delirium in Older Surgical Patients: Incidence, Nursing-Sensitive Correlates, and Outcomes in a Multicenter Chinese Cohort Study. Clin Interv Aging, 2026.PMID 42614798
19. [19]Vishveshwar R, et al. Predictors of Postoperative Delirium in Elderly Patients Undergoing Hemiarthroplasty for Intertrochanteric Femur Fractures: A Prospective Observational Study. Ann Afr Med, 2026.PMID 42593220
20. [20]Maldonado JR, et al. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry, 2013.PMID 24206937
21. [21]Irfan F, et al. Pathophysiology and biomarkers of delirium in older adults-Narrative review. Z Gerontol Geriatr, 2026.PMID 42698026
22. [22]Ishii T, et al. Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profiling. Mol Psychiatry, 2026.PMID 42557393
23. [23]Meza Monge K, et al. From Bench to Bedside: New Frontiers in Understanding and Treating Postoperative Delirium. J Clin Med, 2025.PMID 41375722
24. [24]Chen M, et al. Perioperative neurocognitive disorders as a neuroimmune landscape disorder: microglial priming, state heterogeneity, and time-dependent neuroinflammation. Front Immunol, 2026.PMID 42539432
25. [25]Zhu W, et al. Association between lactate-to-albumin ratio and postoperative delirium in elderly patients undergoing cardiac surgery. J Anesth, 2026.PMID 42573744
26. [26]Wen X, et al. Association of preoperative monocyte level with postoperative delirium in patients receiving cardiac surgery under propofol-based anesthesia: a retrospective study. J Cardiothorac Surg, 2026.PMID 42477770
27. [27]Li M, et al. Association between fever burden and delirium risk after cardiac surgery: A retrospective cohort study based on the MIMIC database. Heart Lung, 2026.PMID 42721638
28. [28]Wang J, et al. Serum C1q as a Novel Predictive Biomarker for Postoperative Delirium After Acute Type A Aortic Dissection. Immun Inflamm Dis, 2026.PMID 42708624
29. [29]Freter S, et al. Translating Delirium Prevention Strategies for Elderly Adults with Hip Fracture into Routine Clinical Care: A Pragmatic Clinical Trial. J Am Geriatr Soc, 2017.PMID 27874185
30. [30]Ke Z, et al. Flexible family visitation and postoperative delirium in an orthopedic intensive care unit: A randomized trial examining surgical-type heterogeneity and cost outcomes. J Int Med Res, 2026.PMID 42432993
31. [31]Grigoryan KV, et al. Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma, 2014.PMID 23912859
32. [32]Aydin FB, et al. The impact of pre- versus postoperative geriatric consultation in elderly patients with hip fractures. Eur J Trauma Emerg Surg, 2026.PMID 42658290
33. [33]Liu TH, et al. Pharmacologic prophylaxis of postoperative delirium in elderly patients: A network meta-analysis of randomized controlled trials. J Psychiatr Res, 2025.PMID 39615080
34. [34]Park SK, et al. Comparative effectiveness of pharmacological interventions to prevent postoperative delirium: a network meta-analysis. Sci Rep, 2021.PMID 34099790
35. [35]Oh ES, et al. Antipsychotics for Preventing Delirium in Hospitalized Adults: A Systematic Review. Ann Intern Med, 2019.PMID 31476766
36. [36]Khan BA, et al. Preventing Postoperative Delirium After Major Noncardiac Thoracic Surgery-A Randomized Clinical Trial. J Am Geriatr Soc, 2018.PMID 30460981
37. [37]Deiner S, et al. Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery: A Randomized Clinical Trial. JAMA Surg, 2017.PMID 28593326
38. [38]Zhong Y, et al. Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis. BMC Anesthesiol, 2025.PMID 40830748
39. [39]Li A, et al. Efficacy and hemodynamic safety of perioperative dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing cardiac surgery: an updated systematic review and meta-analysis of randomized controlled trials. Front Neurol, 2026.PMID 42656262
40. [40]Zhang L, et al. Postoperative Delirium After Dexmedetomidine versus Propofol Sedation in Older Adults Undergoing Hip Fracture Surgery with Spinal Anesthesia: A Randomized Controlled Trial. Drug Des Devel Ther, 2026.PMID 42569644
41. [41]Liu X, et al. Effects of esketamine on postoperative delirium in adult patients: a systematic review and meta-analysis of randomized controlled trials. Front Neurol, 2026.PMID 42694136
42. [42]Roberts WS, et al. The role of opioid analgesics in the development of post-operative delirium: A systematic review and meta-analysis. J Opioid Manag, 2025.PMID 41506699
43. [43]Tillemans MPH, et al. The effect of the anticholinergic burden on duration and severity of delirium in older hip-surgery patients with and without haloperidol prophylaxis: A post hoc analysis. Brain Behav, 2021.PMID 34758516
44. [44]Wildes TS, et al. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA, 2019.PMID 30721296
45. [45]Short TG, et al. Anaesthetic depth and complications after major surgery: an international, randomised controlled trial. Lancet, 2019.PMID 31645286
46. [46]Evered LA, et al. Anaesthetic depth and delirium after major surgery: a randomised clinical trial. Br J Anaesth, 2021.PMID 34465469
47. [47]Cao L, et al. Effect of processed electroencephalography-guided anesthesia on postoperative delirium: an updated systematic review and meta-analysis. Int J Surg, 2025.PMID 41359022
48. [48]Lee JH, et al. Effect of electroencephalography-guided general anesthesia on postoperative delirium : A meta-analysis of randomized controlled trials. Anaesthesiologie, 2026.PMID 42663660
49. [49]Wang Y, et al. The effect of anesthetic depth on postoperative delirium in older adults: a systematic review and meta-analysis. BMC Geriatr, 2023.PMID 37932677
50. [50]Tuerhong S, et al. Electroencephalographic phenotypes of postoperative delirium in the perioperative period. J Anesth Transl Med, 2026.PMID 42416511
51. [51]Long YQ, et al. Dexmedetomidine Infusion Versus Placebo During Light or Deep Anesthesia on Postoperative Delirium in Older Patients Undergoing Major Noncardiac Surgery: A Pilot Randomized Factorial Trial. Anesth Analg, 2024.PMID 37874773
52. [52]Cheung KY, et al. Neuraxial versus general anesthesia in elderly patients undergoing hip fracture surgery and the incidence of postoperative delirium: a systematic review and stratified meta-analysis. BMC Anesthesiol, 2023.PMID 37481517
53. [53]Wang Y, et al. Effects of General Anesthesia Versus Spinal Anesthesia on Early Postoperative Cognition and 30-Day Activities of Daily Living in Elderly Hip Fracture Patients in a Chinese Plateau Region. Int J Gen Med, 2026.PMID 42558879
54. [54]Ikram J, et al. Volatile versus intravenous anesthesia and postoperative neurocognition: A meta-analysis and trial-sequential analysis. J Clin Anesth, 2026.PMID 42275903
55. [55]Somnuke P, et al. Effect of desflurane versus propofol on perioperative neurocognitive disorders in older adults undergoing major urological surgery: a randomized trial. BMC Geriatr, 2026.PMID 42321629
56. [56]Xu X, et al. Effect of phenylephrine versus ephedrine on the incidence of postoperative delirium in elderly patients undergoing non-cardiac and non-neurosurgical procedures: protocol for a multicentre, double-blind, randomized, controlled trial. Ann Med, 2026.PMID 42745683
57. [57]Girard TD, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med, 2018.PMID 30346242
58. [58]Reznik ME, Slooter AJC Delirium Management in the ICU. Curr Treat Options Neurol, 2019.PMID 31724092
59. [59]Leigh V, et al. Effectiveness and harms of pharmacological interventions for the treatment of delirium in adults in intensive care units after cardiac surgery: a systematic review. JBI Database System Rev Implement Rep, 2019.PMID 31449136
60. [60]To-Adithep P, et al. Long-term outcomes of delirium in critically ill surgical patients: A multicenter prospective cohort study. J Psychosom Res, 2023.PMID 37413796
61. [61]Mohanty S, et al. Major Surgery and Long Term Cognitive Outcomes: The Effect of Postoperative Delirium on Dementia in the Year Following Discharge. J Surg Res, 2022.PMID 34731730
62. [62]Labaste F, et al. Postoperative Delirium is a Risk Factor of Poor Evolution Three Years After Cardiac Surgery: An Observational Cohort Study. Clin Interv Aging, 2020.PMID 33376313